Back to search

Switzerland· 65200001

Echinadoron, Lutschtabletten

A medicinal product containing calendula officinalis tm, echinaceae angustifoliae planta tota recens tm, matricariae flos ethanol. infusum tm, registered in Switzerland by Weleda AG and dispensed under Swissmedic category D.

Cat D (Swissmedic)

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedEchinadoron, LutschtablettenATC—REGISTER NO.65200001PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

Swissmedic (Switzerland)
Active substance
calendula officinalis TM, echinaceae angustifoliae planta tota recens TM, matricariae flos ethanol. Infusum TM
Manufacturer
Weleda AG
Country
Switzerland (CH)
ATC code
—
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea780c81-0d34-4e83-ba7c-4c6b0c9a8ef4
GET /v1/drugs/ea780c81-0d34-4e83-ba7c-4c6b0c9a8ef4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Anthroposophische Arzneimittel"
}

See everything about calendula officinalis tm, echinaceae angustifoliae planta tota recens tm, matricariae flos ethanol. infusum tm.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.